Chemoinformaics analysis of Norpseudoephedrine
| Molecular Weight | 151.209 | nRot | 2 |
| Heavy Atom Molecular Weight | 138.105 | nRig | 6 |
| Exact Molecular Weight | 151.1 | nRing | 1 |
| Solubility: LogS | -0.473 | nHRing | 0 |
| Solubility: LogP | -0.184 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 25.6003 |
| nHD | 2 | BPOL | 12.4717 |
| QED | 0.664 |
| Synth | 2.459 |
| Natural Product Likeliness | 0.574 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.175 |
| HIA | 0.009 |
| CACO-2 | -4.884 |
| MDCK | 0.0000184 |
| BBB | 0.927 |
| PPB | 0.257188 |
| VDSS | 2.157 |
| FU | 0.800219 |
| CYP1A2-inh | 0.469 |
| CYP1A2-sub | 0.088 |
| CYP2c19-inh | 0.034 |
| CYP2c19-sub | 0.708 |
| CYP2c9-inh | 0.012 |
| CYP2c9-sub | 0.077 |
| CYP2d6-inh | 0.507 |
| CYP2d6-sub | 0.656 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.312 |
| CL | 5.982 |
| T12 | 0.553 |
| hERG | 0.085 |
| Ames | 0.011 |
| ROA | 0.666 |
| SkinSen | 0.091 |
| Carcinogencity | 0.025 |
| EI | 0.147 |
| Respiratory | 0.694 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.910573 |